AcelRx Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €0.00 -100.0% -€11.13M -29.3% N/A -€10.86M -27.1% N/A
    €557.32K -63.2% -€15.75M -138.5% -2,826.0% -55 pp -€14.89M -37.8% -2,671.6% -11 pp
    €1.52M -37.2% €40.88M -236.1% 2,696.5% +39 pp -€23.94M -0.7% -1,579.2% -5.8 pp
    €2.41M -48.0% -€30.05M -13.1% -1,245.5% -5.0 pp -€24.12M -23.1% -999.8% -3.2 pp
    €4.64M +136.6% -€34.57M -24.2% -745.6% +16 pp -€31.38M -23.2% -676.7% +14 pp
    €1.96M +6.4% -€45.58M +12.9% -2,325.9% -1.3 pp -€40.84M +68.8% -2,084.3% -7.7 pp
    €1.84M -73.1% -€40.36M -8.5% -2,192.0% -15 pp -€24.19M +3.3% -1,313.6% -9.7 pp
    €6.84M -53.9% -€44.10M +19.4% -644.3% -4.0 pp -€23.42M +6.6% -342.2% -1.9 pp
    €14.86M -9.9% -€36.95M +76.9% -248.6% -1.2 pp -€21.98M +38.8% -147.9% -0.52 pp
    €16.49M +269.2% -€20.89M -26.8% -126.7% +5.1 pp -€15.84M -36.1% -96.0% +4.6 pp
    €4.47M -82.3% -€28.55M +42.4% -639.3% -5.6 pp -€24.78M -1,134.0% -554.9% -5.6 pp
    €25.26M +1,132.3% -€20.05M -29.8% -79.4% +13 pp €2.40M -111.8% 9.5% +10 pp
    €2.05M +123.3% -€28.56M +66.0% -1,393.6% +4.8 pp -€20.34M +79.0% -992.3% +2.5 pp
    €917.73K +∞% -€17.21M +40.1% -1,875.1% -19 pp -€11.36M +8.6% -1,237.7% -12 pp
    €0.00 +NaN% -€12.28M -28.7% N/A -€10.46M -36.7% N/A
    €0.00 +NaN% -€17.22M -2.6% N/A -€16.53M +5.2% N/A
    €0.00 -€17.69M N/A -€15.71M N/A

    Notifications